drugset / Trial / NCT06121063
CCT-102 or Expectant Management in Delayed Pregnancy Loss
RandomizedParallel-groupOpen-labelTreatment
Summary
A Phase 3, multi-center clinical trial of a CCT-102 regimen or expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).
Timeline
- Start
- 2023-07-21
- Primary completion
- 2025-05-15
- Completion
- 2025-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CCT-102 A | Unknown | — | Oral |
| Subject | CCT-102 B | Unknown | — | Oral |